Columbus, Ohio-based PriorAuthNow, maker of an electronic prior authorization platform, has closed a $10.5 million Series A funding round. The investment was led by Atlanta-based BIP Capital, with participation from NCT Ventures and Detroit Venture Partners. According to a statement, the funding will primarily be used to advance the company’s operating capabilities and expand its team, with an aim to double its staff over the course of 2018.
from MobiHealthNews https://ift.tt/2wJU5sD
May 16, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Kaiser Permanente Colorado finds there's more to telemedicine than videoWhen people think about direct-to-consumer telemedicine, they often think of video visits or phone calls. But Kaiser Permanente Colorado has discovered that, for the integrated system, a simple text chat is an easier sell — a… Read More
In-Depth: Surging flu is a proving ground for digital health, telemedicineAs the calendar turns to February, the beleaguered US healthcare system continues to battle an influenza season considered by Centers for Disease Control and Surveillance officials to be among the worst of this decade. from … Read More
Edible QR medication could help doctors prescribe more accurately, keep patients more informedIts not uncommon to see customers paying for coffee or boarding a flight using a QR code from their smartphone, but some researchers are now looking to create an edible medication QR code. from MobiHealthNews http://ift.tt/2… Read More
JDRF partners with Cam Med for development of patch-like insulin pumpThe Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexib… Read More
Empatica's consumer-facing epileptic seizure-detecting wearable gets FDA clearanceEmpatica's Embrace, the consumer-facing wearable for epileptic seizure detection, received 510(k) clearance from the FDA last month. The wearable, which has already been used in clinical trials by pharma company Sunovion, has… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment